The results of a major clinical trial, examining the effects of chemotherapy on early phase breast cancer, seem likely to have significant implications for the treatment of women with this condition. The trial, conducted at the University of Birmingham, has found that adding Epirubicin to established chemotherapy drugs can noticeably improve survival rates in early stage breast cancer, reducing the risk of death by up to 30%.
Dont be misled by their "survival rates"
you simply cannot poisen a body back to health.
Start by correcting latent acidosis.
invista360 3 years ago
youtube: live blood analysis following chemotherapie.
Is it any wonder that chemoradiation kills 1500 people a day/545,000 year, U.S. alone.
9 out of 10 oncologists polled said they would never submit to chemoradiation themselves if they had cancer!!
invista360 3 years ago
Medical liabilty System endorsed Chemotherapy= EXTERMINation! SOUL ARMOUR
NAMTOH1 4 years ago